Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 459

1.

Psychological Resources, Constructive Conflict Management Behaviors, and Depressive Symptoms: A Dyadic Analysis.

Lee S, King V, Wickrama KKAS, O'Neal CW.

Fam Process. 2019 Sep 9. doi: 10.1111/famp.12486. [Epub ahead of print]

PMID:
31497888
2.

Characterization of novel small RNAs (sRNAs) contributing to the desiccation response of Salmonella enterica serovar Typhimurium.

Barnhill EC, Crucello A, Houserova D, King VM, Amin SV, Roberts JT, Zambrano ME, DeMeis JD, Dahmer DJ, Ijaz Z, Barchie AA, Watters BC, Prusak JE, Dean MA, Holton NW, Ferreira-Filho JA, Sant'Ana AS, Spector MP, Borchert GM.

RNA Biol. 2019 Nov;16(11):1643-1657. doi: 10.1080/15476286.2019.1653680. Epub 2019 Aug 15.

PMID:
31390935
3.

Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP): A Phase II, Multicenter, Randomized, Controlled Trial.

Hodgson CL, Cooper DJ, Arabi Y, King V, Bersten A, Bihari S, Brickell K, Davies A, Fahey C, Fraser J, McGuinness S, Murray L, Parke R, Paul E, Tuxen D, Vallance S, Young M, Nichol A; PHARLAP Study Investigators and the ANZICS Clinical Trials Group.

Am J Respir Crit Care Med. 2019 Jul 29. doi: 10.1164/rccm.201901-0109OC. [Epub ahead of print]

PMID:
31356105
4.

Patterns of Shared Religious Attendance and Positive Stepfamily Functioning.

King V, Lindstrom R, Washington C.

J Res Adolesc. 2019 Jun;29(2):357-368. doi: 10.1111/jora.12409.

PMID:
31206882
5.

Comparative efficacy of topical treatments with Revolution® Plus (selamectin and sarolaner) and Bravecto® for Cats (fluralaner) against Ixodes scapularis ticks on cats.

Vatta AF, Young DR, King VL, Myers MR.

Vet Parasitol. 2019 Jun;270 Suppl 1:S58-S63. doi: 10.1016/j.vetpar.2019.05.012. Epub 2019 Jun 3.

PMID:
31182302
6.

Production of Antigen-Specific Human CD4+ T Cell Lines and Clones.

Matthis J, King V, Reijonen H.

Methods Mol Biol. 2019;1988:387-402. doi: 10.1007/978-1-4939-9450-2_27.

PMID:
31147954
8.

Accelerated storage test of betalains extracted from the peel of pitaya (Hylocereus cacti) fruit.

Chew YM, Hung CH, King VA.

J Food Sci Technol. 2019 Mar;56(3):1595-1600. doi: 10.1007/s13197-019-03673-1. Epub 2019 Mar 4.

PMID:
30956340
9.

Using rapid reviews to strengthen health policy and systems and progress towards universal health coverage.

Langlois EV, Straus SE, Antony J, King VJ, Tricco AC.

BMJ Glob Health. 2019 Feb 5;4(1):e001178. doi: 10.1136/bmjgh-2018-001178. eCollection 2019. No abstract available.

10.

Randomized controlled trial of harm reduction treatment for alcohol (HaRT-A) for people experiencing homelessness and alcohol use disorder.

Collins SE, Clifasefi SL, Nelson LA, Stanton J, Goldstein SC, Taylor EM, Hoffmann G, King VL, Hatsukami AS, Cunningham ZL, Taylor E, Mayberry N, Malone DK, Jackson TR.

Int J Drug Policy. 2019 May;67:24-33. doi: 10.1016/j.drugpo.2019.01.002. Epub 2019 Mar 6.

PMID:
30851620
11.

Treatment of Synchronous Traumatic Perforations of the Trachea and the Esophagus With Two Inferiorly Based Strap Muscle Interposition Flaps: An Innovative Approach.

Rammos CK, Anderson RC, Taege SM, King VA, Yoo A.

J Craniofac Surg. 2019 Jun;30(4):e330-e332. doi: 10.1097/SCS.0000000000005234.

PMID:
30845090
12.

Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.

Vatta AF, Myers MR, Rugg JJ, Chapin S, Pullins A, King VL, Rugg D.

Vet Parasitol. 2019 Jun;270 Suppl 1:S3-S11. doi: 10.1016/j.vetpar.2018.11.009. Epub 2018 Dec 4.

13.

The speed of kill of a topical combination of selamectin plus sarolaner against induced infestations of Ixodes scapularis ticks on cats.

Vatta AF, Everett WR, Cherni JA, King VL, Rugg D.

Vet Parasitol. 2019 Jun;270 Suppl 1:S26-S30. doi: 10.1016/j.vetpar.2018.10.016. Epub 2018 Nov 1.

14.

Efficacy and safety of a new topical formulation of selamectin plus sarolaner in the treatment and control of natural infections of Ancylostoma tubaeforme and Toxocara cati in cats presented as veterinary patients in the United States.

Vatta AF, Myers MR, Bowman DD, Rugg JJ, Damrah L, Therrien C, Liotta JL, Lucio-Forster A, King VL, Rugg D.

Vet Parasitol. 2019 Jun;270 Suppl 1:S45-S51. doi: 10.1016/j.vetpar.2018.10.012. Epub 2018 Nov 11.

15.

Efficacy of a new topical formulation containing selamectin plus sarolaner against three common tick species infesting cats in the United States.

Vatta AF, Young DR, Everett WR, King VL, Cherni JA, von Reitzenstein M, Holzmer SJ, Chapin S, Rugg D.

Vet Parasitol. 2019 Jun;270 Suppl 1:S19-S25. doi: 10.1016/j.vetpar.2018.10.013. Epub 2018 Nov 11.

16.

Efficacy of a topical formulation of selamectin plus sarolaner against induced infestations of Amblyomma americanum on cats and prevention of Cytauxzoon felis transmission.

Reichard MV, Rugg JJ, Thomas JE, Allen KE, Barrett AW, Murray JK, Herrin BH, Beam RA, King VL, Vatta AF.

Vet Parasitol. 2019 Jun;270 Suppl 1:S31-S37. doi: 10.1016/j.vetpar.2018.10.018. Epub 2018 Nov 11.

17.

The efficacy of a novel topical formulation of selamectin plus sarolaner (Revolution® Plus/Stronghold® Plus) in preventing the development of Dirofilaria immitis in cats.

McTier TL, Pullins A, Chapin S, Rugg J, von Reitzenstein M, McCall JW, King VL, Vatta AF.

Vet Parasitol. 2019 Jun;270:56-62. doi: 10.1016/j.vetpar.2018.10.010. Epub 2018 Oct 15.

18.

ADAR Mediated RNA Editing Modulates MicroRNA Targeting in Human Breast Cancer.

Roberts JT, Patterson DG, King VM, Amin SV, Polska CJ, Houserova D, Crucello A, Barnhill EC, Miller MM, Sherman TD, Borchert GM.

Processes (Basel). 2018 May;6(5). pii: 42. doi: 10.3390/pr6050042. Epub 2018 Apr 25.

19.

Two-stage Reconstruction of the Large and Ptotic Breasts: Skin Reduction Mastectomy with Prepectoral Device Placement.

Rammos CK, Mammolito D, King VA, Yoo A.

Plast Reconstr Surg Glob Open. 2018 Jul 12;6(7):e1853. doi: 10.1097/GOX.0000000000001853. eCollection 2018 Jul.

20.

The influence of mastery on mother's health in middle years: Moderating role of stressful life context.

King V, Wickrama KAS, Klopack ET, Lorenz FO.

Stress Health. 2018 Oct;34(4):552-562. doi: 10.1002/smi.2816. Epub 2018 Jun 7.

21.

Parent-Adolescent Closeness, Family Belonging, and Adolescent Well-Being Across Family Structures.

King V, Boyd LM, Pragg B.

J Fam Issues. 2018 May;39(7):2007-2036. doi: 10.1177/0192513X17739048. Epub 2017 Nov 7.

22.

Immediate Postpartum LARC: An Underused Contraceptive Option.

Ray MK, King V.

Am Fam Physician. 2018 Jan 1;97(1):9-10. No abstract available.

23.

Stressful Work Trajectories and Depressive Symptoms in Middle-Aged Couples: Moderating Effect of Marital Warmth.

Wickrama KAS, King VA, O'Neal CW, Lorenz FO.

J Aging Health. 2017 Oct 1:898264317736135. doi: 10.1177/0898264317736135. [Epub ahead of print]

PMID:
29254406
24.

Chronic inflammation and impaired development of the preterm brain.

Bennet L, Dhillon S, Lear CA, van den Heuij L, King V, Dean JM, Wassink G, Davidson JO, Gunn AJ.

J Reprod Immunol. 2018 Feb;125:45-55. doi: 10.1016/j.jri.2017.11.003. Epub 2017 Nov 26. Review.

PMID:
29253793
25.

Prepectoral Immediate Direct-to-Implant Breast Reconstruction with Anterior AlloDerm Coverage.

Jones G, Yoo A, King V, Jao B, Wang H, Rammos C, Elwood E.

Plast Reconstr Surg. 2017 Dec;140(6S Prepectoral Breast Reconstruction):31S-38S. doi: 10.1097/PRS.0000000000004048.

PMID:
29166345
26.

Colorectal Cancer Screening: An Educational Intervention for Nurse Practitioners to Increase Screening Awareness and Participation
.

Slyne TC, Gautam R, King V.

Clin J Oncol Nurs. 2017 Oct 1;21(5):543-546. doi: 10.1188/17.CJON.543-546.

PMID:
28945710
27.

Maternal buprenorphine treatment and infant outcome.

Jansson LM, Velez ML, McConnell K, Spencer N, Tuten M, Jones H, Rios R, King VL, Gandotra N, Millio L, DiPietro JA.

Drug Alcohol Depend. 2017 Nov 1;180:56-61. doi: 10.1016/j.drugalcdep.2017.08.001. Epub 2017 Aug 31.

28.

Task-Specific Training for Adults With Chronic Knee Pain: A Case Series.

Bove AM, Baker N, Livengood H, King V, Mancino J, Popchak A, Fitzgerald GK.

J Orthop Sports Phys Ther. 2017 Aug;47(8):548-556. doi: 10.2519/jospt.2017.7349. Epub 2017 Jul 13.

PMID:
28704627
29.

Human snoRNA-93 is processed into a microRNA-like RNA that promotes breast cancer cell invasion.

Patterson DG, Roberts JT, King VM, Houserova D, Barnhill EC, Crucello A, Polska CJ, Brantley LW, Kaufman GC, Nguyen M, Santana MW, Schiller IA, Spicciani JS, Zapata AK, Miller MM, Sherman TD, Ma R, Zhao H, Arora R, Coley AB, Zeidan MM, Tan M, Xi Y, Borchert GM.

NPJ Breast Cancer. 2017 Jul 10;3:25. doi: 10.1038/s41523-017-0032-8. eCollection 2017.

30.
31.

Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.

Calvert JG, Keith ML, Pearce DS, Lenz MC, King VL, Diamondidis YA, Ankenbauer RG, Martinon NC.

Vet Microbiol. 2017 Jun;205:80-83. doi: 10.1016/j.vetmic.2017.03.037. Epub 2017 May 2.

PMID:
28622868
32.

MicroRNA Expression: Protein Participants in MicroRNA Regulation.

King VM, Borchert GM.

Methods Mol Biol. 2017;1617:27-37. doi: 10.1007/978-1-4939-7046-9_2. Review.

PMID:
28540674
33.

Age and gender considerations for technology-assisted delivery of therapy for substance use disorder treatment: A patient survey of access to electronic devices.

Antoine D, Heffernan S, Chaudhry A, King V, Strain EC.

Addict Disord Their Treat. 2016 Dec;15(4):149-156. doi: 10.1097/ADT.0000000000000088.

34.

Elevated ACKR2 expression is a common feature of inflammatory arthropathies.

Baldwin HM, Singh MD, Codullo V, King V, Wilson H, McInnes I, Graham GJ.

Rheumatology (Oxford). 2017 Sep 1;56(9):1607-1617. doi: 10.1093/rheumatology/kex176.

35.

Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: A randomized controlled trial.

Schacht RL, Brooner RK, King VL, Kidorf MS, Peirce JM.

J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. Epub 2017 Apr 17.

36.

Efficacy of a new spot-on formulation of selamectin plus sarolaner against Ancylostoma tubaeforme and Toxocara cati in cats.

Geurden T, Vatta AF, Slootmans N, King VL, Lin D, McTier T, Rugg D.

Vet Parasitol. 2017 Apr;238 Suppl 1:S31-S35. doi: 10.1016/j.vetpar.2017.02.027.

37.

Efficacy of a new spot-on formulation of selamectin plus sarolaner against four common tick species infesting cats in Europe.

Geurden T, Becskei C, Vatta AF, Slootmans N, von Reitzenstein M, King VL, Lin D, Rugg D.

Vet Parasitol. 2017 Apr;238 Suppl 1:S3-S7. doi: 10.1016/j.vetpar.2017.02.028.

38.

Efficacy of a new spot-on formulation of selamectin plus sarolaner in the treatment of Otodectes cynotis in cats.

Becskei C, Reinemeyer C, King VL, Lin D, Myers MR, Vatta AF.

Vet Parasitol. 2017 Apr;238 Suppl 1:S27-S30. doi: 10.1016/j.vetpar.2017.02.029.

39.

Efficacy of a new spot-on formulation of selamectin plus sarolaner for cats against adult Ctenocephalides felis, flea egg production and adult flea emergence.

Vatta AF, Everett WR, Holzmer SJ, Cherni JA, King VL, Rugg D, Geurden T.

Vet Parasitol. 2017 Apr;238 Suppl 1:S22-S26. doi: 10.1016/j.vetpar.2017.02.026.

40.

Efficacy and speed of kill of a new spot-on formulation of selamectin plus sarolaner against flea infestations in cats.

Becskei C, Cherni JA, Vatta AF, King VL, Lin D, Rugg D.

Vet Parasitol. 2017 Apr;238 Suppl 1:S18-S21. doi: 10.1016/j.vetpar.2017.03.010.

41.

US immigration order strikes against biotech.

Levin JM, Holtzman SH, Maraganore J, Hastings PJ, Cohen R, Dahiyat B, Adams J, Adams C, Ahrens B, Albers J, Aspinall MG, Audia JE, Babler M, Barrett P, Barry Z, Bermingham N, Bloch S, Blum RI, Bolno PB, Bonney MW, Booth B, Bradbury DM, Brauer SK, Byers B, Cagnoni PJ, Cali BM, Ciechanover I, Clark C, Clayman MD, Cleland JL, Cobb P, Cooper R, Currie MG, Diekman J, Dobmeier EL, Doerfler D, Donley EL, Dunsire D, During M, Eckstein JW, Elenko E, Exter NA, Fleming JJ, Flesher GJ, Formela JF, Forrester R, Francois C, Franklin H, Freeman MW, Furst H, Gage LP, Galakatos N, Gallagher BM, Geraghty JA, Gill S, Goeddel DV, Goldsmith MA, Gowen M, Goyal V, Graney T, Grayzel D, Greene B, Grint P, Gutierrez-Ramos JC, Haney B, Ha-Ngoc T, Harris T, Hasnain F, Hata YS, Hecht P, Henshaw L, Heyman R, Hoppenot H, Horvitz HR, Hughes TE, Hutton WS, Isaacs ST, Jenkins A, Jonker J, Kaplan J, Karsen P, Keiper J, Kim J, Kindler J, King R, King V, Kjellson N, Koenig S, Koenig G, Kolchinsky P, Laikind P, Langer RB, Lee JJ, Leff JS, Leicher BA, Leschly N, Levin A, Levin M, Levine AJ, Levy A, Liu DR, Lodish HF, Lopatin U, Love TW, Macdonald G, Maderis GJ, Mahadevia A, Mahanthappa NK, Martin JF, Martin A, Martucci WE, McArthur JG, McCann CM, McCarthy SA, McDonough CG, Mendlein J, Miller L, Miralles D, Moch KI, More B, Myers AG, Narachi MA, Nashat A, Nelson W, Newell WJ, Olle B, Osborn JE, Owens JC, Pande A, Papadopoulos S, Parker HS, Parmar KM, Patterson MR, Paul SM, Perez R, Perry M, Pfeffer CG, Powell M, Pruzanski M, Purcell DJ, Rakhit A, Ramamoorthi K, Rastetter W, Rawcliffe AA, Reid LE, Renaud RC, Rhodes JP, Rieflin WJ, Robins C, Rocklage SM, Rosenblatt M, Rosin JG, Rutter WJ, Saha S, Samuels C, Sato VL, Scangos G, Scarlett JA, Schenkein D, Schreiber SL, Schwab A, Sekhri P, Shah R, Shenk T, Siegall CB, Simon NJ, Simonian N, Stein J, Su M, Szela MT, Taglietti M, Tandon N, Termeer H, Thornberry NA, Tolar M, Ulevitch R, Vaishnaw AK, VanLent A, Varsavsky M, Vlasuk GP, Vounatsos M, Waksal SG, Warma N, Watts RJ, Werber Y, Westphal C, Wierenga W, Williams DE, Williams LR, Xanthopoulos KG, Zohar D, Zweifach SS.

Nat Biotechnol. 2017 Mar 7;35(3):204-206. doi: 10.1038/nbt.3824. No abstract available.

PMID:
28267733
42.

Maternal buprenorphine treatment and fetal neurobehavioral development.

Jansson LM, Velez M, McConnell K, Spencer N, Tuten M, Jones HE, King VL, Gandotra N, Milio LA, Voegtline K, DiPietro JA.

Am J Obstet Gynecol. 2017 May;216(5):529.e1-529.e8. doi: 10.1016/j.ajog.2017.01.040. Epub 2017 Feb 7.

43.

The Risk of MI and Ischemic Stroke with Combined Oral Contraceptives.

Nettleton W, King V.

Am Fam Physician. 2016 Nov 1;94(9):691-692. No abstract available.

44.

Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses.

Garritty C, Stevens A, Gartlehner G, King V, Kamel C; Cochrane Rapid Reviews Methods Group.

Syst Rev. 2016 Oct 28;5(1):184.

45.

Derivatives of the pyrazolo[1,5-a]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastoma.

Werry EL, King VA, Barron ML, Banister SD, Sokias R, Kassiou M.

Eur J Pharm Sci. 2017 Jan 1;96:186-192. doi: 10.1016/j.ejps.2016.09.026. Epub 2016 Sep 19.

PMID:
27658888
46.

Factors Associated With Perceptions of Family Belonging Among Adolescents.

King V, Boyd LM.

J Marriage Fam. 2016 Aug;78(4):1114-1130. Epub 2016 Jun 13.

47.

My Mother's Husband: Factors Associated with How Adolescents Label their Stepfathers.

Thorsen ML, King V.

J Soc Pers Relat. 2016 Sep;33(6):835-851. Epub 2015 Aug 13.

48.

Factors associated with early marijuana initiation in a criminal justice population.

Savage RJ, King VL, Clark CB, Cropsey KL.

Addict Behav. 2017 Jan;64:82-88. doi: 10.1016/j.addbeh.2016.08.005. Epub 2016 Aug 10.

PMID:
27572181
49.

Tantalum trabecular metal implants in anterior cervical corpectomy and fusion: 2-year prospective analysis.

King V, Swart A, Winder MJ.

J Clin Neurosci. 2016 Oct;32:91-4. doi: 10.1016/j.jocn.2016.03.026. Epub 2016 Aug 8.

PMID:
27515543
50.

Narrow-band 1 W source at 257 nm using frequency quadrupled passively Q-switched Yb:YAG laser.

Goldberg L, Cole B, McIntosh C, King V, Hays AD, Chinn SR.

Opt Express. 2016 Jul 25;24(15):17397-405. doi: 10.1364/OE.24.017397.

PMID:
27464186

Supplemental Content

Support Center